RNA's Advantages Over Other Cell Therapies With Cartesian's CSO
Source: Cell & Gene
![22_01_CGPodcast_1200x628_Ep14 22_01_CGPodcast_1200x628_Ep14](https://vertassets.blob.core.windows.net/image/95421f91/95421f91-de88-4d8e-a7be-167933e9f1ab/375_250-22_01_cgpodcast_1200x628_ep14.png)
Dr. Michael Singer, CSO at Cartesian Therapeutics, details why RNA has advantages over other cell therapies, the company's three RNA trials, and the therapeutic benefit of multiple modifications.
This website uses cookies to ensure you get the best experience on our website. Learn more